MDM2SNP309and p53 Codon 72 Genetic Polymorphisms
|
|
- Barnard McBride
- 6 years ago
- Views:
Transcription
1 Annals of Clinical & Laboratory Science, vol. 44, no. 4, 2014 Available online at MDM2SNP309and p53 Codon 72 Genetic Polymorphisms and Risk of AML: an Egyptian Study Nabil Mohsen El-Danasouri 1, Shadia Hassan Ragab 2, Maha Ameen Rasheed 2, Zainab Ali El_Saadany 1, and Safa Nabil Abd El-Fattah 2 1 Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, and 2 National Research Center, Egypt Abstract. Background: Acute myeloid leukemia (AML) is a heterogeneous disease with numerous genetic abnormalities corresponding to a variety of subtypes. p53 is involved in multiple cellular pathways including apoptosis, transcriptional control, and cell cycle regulation. A single nucleotide polymorphism (SNP) at codon 72 of the p53 gene is associated with the risk for development of various neoplasms. MDM2 SNP309 is a single nucleotide T to G polymorphism located in the MDM2 gene promoter, which enhances the expression of MDM2 protein and thereby leads to attenuation of the p53 stress response. Objective: The current study aimed to define the roles of MDM2 and p53 genetic polymorphisms with the risk of AML. Methodology: Genotyping for MDM2 was done by AS-PCR technique while p53 codon 72 genotyping was done by PCR- RFLP for 50 patients and 50 controls. Results: The study did not detect any significant differences regarding MDM2 or p53 polymorphisms in AML cases, as compared to controls. A borderline significance was found between cases and controls regarding combined MDM2 T/G and p53 genotyping. MDM2 variant genotype was significantly associated with a younger age group and lower Hb level, while the P53 variant was significantly associated with less frequent CD117 expression. Key words: MDM2, p53 codon 72, AML, AS-PCR, RFLP-PCR. 449 Introduction Acute myeloid leukemia (AML) refers to a group of marrow-based neoplasms characterized by the presence of blasts and/or blast equivalents accumulating in the bone marrow and interfering with the production of normal blood cells. AML is the most common acute leukemia affecting adults, and its incidence increases with age [1]. The majority of AML cases are associated with nonrandom chromosomal translocations that result in gene rearrangements [2]. Recurrent balanced aberrations have been identified in AML, with the frequencies of the four most common translocations, i.e. PML-RARα, AML1-ETO, CBFβ-MYH11 and MLL-fusions, between 3% and 10%. For others, the prevalence is significantly smaller (1-2%) [3]. These genetic abnormalities were incorporated in the WHO classification for diagnosis of AML [4]. Address correspondence to Zainab Ali El_Saadany, MD, Assistant Professor, Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Egypt; phone/fax: ; e mail: zinab573@hotmail.com The p53 protein is a principal mediator of growth arrest, apoptosis, and senescence in response to an array of cellular damage [5-7]. Various types of stress can induce high levels of p53 protein, thus preventing inappropriate propagation of stressed cells. Because of this protein s vital role in maintaining normal cellular function, tumor cells have developed numerous methods to disable its function. Indeed, the p53 protein is inactivated by mutations or deletions in approximately 50% of human cancers [8]. A polymorphism at codon 72 with a single-base change in the p53 gene causes an amino acid replacement [Arg (CGC) with Pro (CCC)] in the transaction domain of the protein. Although the functional differences of these two variants of the p53 protein remain unclear, it has been demonstrated that a single nucleotide polymorphism (SNP) at codon 72 of the p53 gene is associated with the risk for development of various neoplasms. However, in the remainder of human tumor types, the p53 gene remains in a wildtype form, with its activity eradicated by its principal cellular inhibitor, murine double minute 2 protein (MDM2) [9] /14/ by the Association of Clinical Scientists, Inc.
2 450 Annals of Clinical & Laboratory Science, vol. 44, no. 4, 2014 AML was based on morphological, immunophenotyping, and cytochemical criteria of the French American British (FAB) system [12,13] and WHO classification [4], and a cutoff of 20% was used to confirm positivity of cytoplasmic MPO done by flow cytometry [14]. Monoclonal Mouse Anti-Human Myeloperoxidase was used after fixation and permeabilization of blast cells (Dako, Denmark). Figure 1. Genotyping of MDM2 SNP309 and p53 codon 72 polymorphism in the studied AML cases. Upper panel: P53 codon 72 genotyping by PCR-RFLP technique:lanes 3, 4, 6 & 8: Homozygous Arg/Arg genotype.lanes 2 & 5: Homozygous Pro/Pro genotype.lanes 1, 7, 9 & 10: Heterozygous Arg/Pro genotype. Lower panel: MDM2 SNP309 genotyping by AS-PCR:Lanes 3a-3b: Wild TT genotype.lanes 1a-1b, 2a-2b, 4a-4b & 5a-5b: Heterozygous TG genotype.m: DNA molecular weight marker ladder. The MDM2 protein provides negative feedback for the tumor suppressor gene, p53. Transcription of MDM2 is activated by p53 and MDM2, which then acts as an E3 ubiquitin ligase that exports p53 out of the nucleus and promotes its degradation. A normal interaction between the two proteins allows p53 to be maintained at low levels in normally dividing cells [10]. A single nucleotide polymorphism (SNP) at position 309 (SNP 309) in the promoter region of MDM2 results in increased affinity for transcription factor Sp1 and subsequent overexpression of MDM2, downregulation of p53 response, and increased tumor genesis [11]. To determine the role of these two genes in acute leukemias, we studied the risk of MDM2 SNP309 and p53 codon 72 polymorphisms in acute myeloid leukemia. Materials and Methods Study population. This study was comprised of 50 adult Egyptian de-novo AML patients and 50 age and gender matched healthy controls. Cases were selected from Kasr El-Aini Teaching Hospital, Cairo University, Egypt. There were 26 males and 24 females, whose ages ranged from years with a mean age of years. The research protocol was approved by the research Ethics Committee of the Departments of Clinical Pathology and Medical Oncology, Cairo University. Diagnosis of DNA extraction and genotyping. Genomic DNA extraction from peripheral blood leucocytes was done using QIAamp DNA Blood Mini Kit (QIAGEN Germany), following the manufacturer s instructions. DNA samples were routinely stored at -20 C. Genotyping of p53 codon 72 Arg/Pro polymorphism was determined using PCR-based restriction fragment length polymorphism (RFLP) method [15]. The forward primer used was 5 ATCTACAGTCCCCCTTGCCG-3, whereas the reverse primer was 5 GCAACTGACCGTGCAAGTCA-3. PCR conditions were 94 C for 5min, followed by 35 cycles of 94 C for 30 s, 56 C for 30 s and 72 C for 30 s. The final extension was at 72 C for 7 min. The amplified PCR product (296 bp) was digested by restriction enzyme BstUI (New England Biolabs, UK). The DNA fragments were electrophoresed through a 3% agarose gel and stained with ethidium bromide. The Arg allele produced two small fragments of 169 and 127 bp. The Pro allele produced a single 296-bp band. The heterozygous genotype produced three bands of 296, 169 and 127 bp (Figure 1). Genotyping of MDM2 SNP309 was performed using an allele-specific polymerase chain reaction (AS-PCR) [15]. DNA was amplified by PCR reaction using primer pairs specific for the two alleles: primers F1 (5 GGATTTCGGACGGCTCTC-3 ) and R1 (5 TCCGGACCTCCCGCGCCGA- 3 ) were used to amplify the 121-bp wild-type allele (T), and primers F2 (5 GTTTTGTTGGACTGGGGCTA-3 ) and R2 (5 ATCCGGACCTCCCGCGCCGC-3 ) were used to amplify the 168-bp mutant allele (G). Two independent PCR assays were performed for each allele. The reaction conditions were set as follows: for the wild-type T allele: 94 C for 5 min; 5 cycles of 94 C for 30 s, 62 C for 30 s; 35 cycles of 94 C for 30 s, 58 C for 30 s, and 72 C for 30 s; with a final extension at 72 C for 7min in the last cycle. For the mutant G allele: 94 C for 5 min; 5 cycles of 94 C for 30 s, 65 C for 30 s; 35 cycles of 94 C for 30s, 62 C for 30 s, and 72 C for 30 s; with a final extension at 72 C for 7 min in the last cycle. The amplification products were run by electrophoresis on a 3% agarose gel stained with ethidium bromide (Figure 1). Statistical Analysis. The data were analyzed using Statistical Package for Social Science (SPSS) program version 15. Numerical data were summarized as mean and standard deviation or median and range as appropriate. Non-parametric test (Mann Whitney U test) was
3 Table 1. Clinical and laboratory characteristics of AML patients. Character used for analysis of quantitative data, as data were not symmetrically distributed. Chi Square test and Fisher s exact test were used for analysis of qualitative data (Fisher s exact test was used when > 20% of variables were <5 or when one variable was <1). Logistic regression was used for calculation of odds ratio (OR) with 95% confidence interval (CI) for risk estimation. A P-value < 0.05 was considered significant. Results No. Sex Male 26 Female 24 Age Mean ± SD 41.58±13.96 Laboratory data WBC count (x10x 9 /L) Median (range) 91.7 ( ) Hb (g/dl) Median (range) 6.8 ( ) Platelet count (x10x 9 /L) Median (range) 55.5 ( ) PB blasts (%) Median (range) 40 ( ) BM blasts (%) Median (range) 60 ( ) FAB subtypes M0 2 M1 14 M2 14 M3 8 M4 8 M5 4 Immunophenotyping (done by flow cytometry) CD34 19 HLA-DR 31 Cyt-MPO 48 CD33 47 CD13 40 CD CD14 12 PB: Peripheral blood; BM: bone marrow The clinical and laboratory characteristics of AML patients are presented in Table 1. The frequency of the studied genes among AML patients and controls are presented in Table 2. There was no significant difference in the distribution of MDM2 SNP309 variant genotypes between AML cases and controls (p=>0.99). The frequencies of wild and variant genotypes in cases versus controls was 2%/4% and 98%/96% respectively. Regarding the p53 codon 72 polymorphism, there was also no significant difference in the distribution of variant genotype among cases and controls (p= 0.08), as the frequency of wild and variant genotype in cases versus controls was 40%/28% and 60%/72% respectively. Studying the combined genotyping of MDM2 and p53 genes and risk of AML, a borderline significant difference was found between AML patients and controls: the combined hetero MDM2 TG and p53 Pro/Pro variants were higher in AML patients (p=0.049) Table 3. Further analysis of the influence of the studied genetic polymorphisms on the clinical and laboratory characteristics of the patients revealed a significant younger AML age of onset (mean 32 years) and lower Hb level (median 6.2 g/dl) associated with the MDM2 SNP309 GG genotype (p=0.02 and respectively), while the p53 variant genotype showed significance for a lower number of AML patients expressing CD117 (p=0.004). They were either M1 or M2 patients. There was no significant difference in regards to other clinical and laboratory data or FAB subtypes concerning the two genes. However, M1 and M2 subtypes showed a higher frequency of MDM2 309 GG genotype than other subtypes. Discussion MDM2 and p53 polymorphism in AML 451 At the National Cancer Institute of Cairo University, Egypt, acute leukemias accounted for 7% of the newly diagnosed malignant cases registered in the time period between January 2002 and December Acute myeloid leukemia accounted for approximately 41.5% of these newly diagnosed acute leukemias and for 4.6% of all cancer cases [16]. The triennial report of Gharbiah population-based cancer registries (GPCR) reported similar data [17]. Several genetic polymorphisms have been identified as risk factors for leukemia by meta-analyses
4 452 Annals of Clinical & Laboratory Science, vol. 44, no. 4, 2014 Table 2. The frequency of the studied genes among AML patients and controls. Genotypes Cases Controls OR (95% CI) P value (n=50), no. (%) (n=50) no. (%) MDM2 309 T>G Wild TT 1(2) 2 (4) 1.0 (Ref.) Hetero TG 42 (84) 42 (84) 2 ( ) >0.99 Homo GG 7 (14) 6 (12) 2.33 ( ) >0.99 TG + GG 49 (98) 48 (96) 2.04 ( ) >0.99 P53 codon 72 Arg>Pro Arg/Arg 20 (40) 14 (28) 1.0 (Ref.) Arg/Pro 20 (40) 31 (62) 0.45 ( ) 0.12 Pro/Pro 10 (20) 5 (10) 1.4 ( ) 0.75 Arg/Pro + Pro/Pro 30 (60) 36 (72) 0.58 ( ) 0.34 Fisher s exact test [18-20]. Nevertheless, despite the importance of genetic factors, only a few gene polymorphisms associated with leukemia susceptibility have been identified so far [21]. Loss of p53 plays an important role in the pathogenesis of cancer, and its negative regulator MDM2 has also been suggested to be mutated in a variety of cancers [22]. In the current study, we examined fifty de novo AML patients and fifty age and sex matched control subjects to explore whether the common polymorphisms in MDM2 SNP309 and p53 codon 72 would affect the risk for AML in the Egyptian population. We observed no association between MDM2 SNP309 and risk of AML, which was consistent with another Egyptian study done by Ebid et al. [23]. Our study is somewhat similar to that reported by Ellis et al. [24], who studied associations between t-aml and two common functional P53- pathway variants, the MDM2 SNP309 and the P53 codon 72 polymorphism. They showed that the MDM2 SNP309G allele was associated with a modest increased risk in de novo AML but not in therapy-related AML. Phang et al. [25] claimed that the MDM2 SNP309G allele reduced the risk of the disease in a Singaporean Chinese population. Our results are inconsistent with a case-control study from a northern Chinese population. They observed a nearly 3.52-fold increase in AML risk associated with the MDM2 GG genotype compared with the MDM2 TT genotype (p=0.001) [15]. Many publications also showed a significant association of the MDM2 T309G polymorphism with leukemia risk. The ORs of this meta-analysis ranged from 1.2 to 1.47, thus indicating that individuals carrying a homozygous G allele may have an increased leukemia risk compared with those bearing a wild-type T allele [21]. This difference in results may be due to the larger number of patients in the Chinese study. A larger number of patients should be incorporated in a study to determine whether the difference is actually due to the number of patients or merely due to the ethnic and/or geographic variations of the frequency of these alleles in different healthy populations [26,27]. Also proposed is the possibility that carcinogen exposure in different populations, combined with genetic background, may affect the frequency of aforementioned alleles [15]. In our study, no association between the p53 codon 72 polymorphism and risk of AML was found; there was no significant difference between p53 genotypes (Arg/Arg, Arg/Pro and Pro/Pro) in the AML cases and control groups, with p value of This is consistent with a case-control study from a northern Chinese population (p=0.25) [15]. Similarly, several studies (23,24,28,29) reported no association of p53 genotypes with risk of de novo AML. A meta-analysis of thirteen case-control studies showed significant associations between the p53 Arg72Pro polymorphism and lymphoma
5 Table 3. Comparison of combined genotype analysis of MDM2 SNP309 and p53 codon 72 between AML patients and controls. Genotypes Case Controls P value MDM2 P53 no. (%) no. (%) Arg/Arg 2 (28.6) 1 (16.7) Homo GG Pro/Pro 1 (14.3) 1 (16.7) > 0.99 Arg/Pro 4 (57.1) 4 (66.6) Arg/Arg (40.5) 11 (26.2) Hetero TG Pro/Pro 9 (21.4) 4 (9.5) Arg/Pro (38.1) 27 (64.3) Arg/Arg 1 (100) 2 (100) Wild TT Pro/Pro 0 0 > 0.99 Arg/Pro 0 0 Chi Square test (non-hodgkin lymphoma) risk, while no significant association was found between this polymorphism and leukemia risk [30]. A single study conducted on acute leukemia cases found a significant association between homozygous Arg genotype and AML (p < 0.001), indicating that Arg/Arg genotype might confer increased risk to development of acute myeloid leukemia [31]. Present work shows that the MDM2 309 GG genotype is significantly associated with an earlier age of onset of AML. Many studies of leukemia are controversial, showing this association in Caucasian and Black populations but not in Hispanic and Singaporean populations [25,32]. Phillips et al. also showed that the variant SNP309 influences susceptibility to pediatric AML, where the GG genotype was associated with an increased susceptibility to AML [33]. Xiong et al. [15] showed that the SNP309 has no effect on the timing of acute leukemia onset in the northern Chinese population, which further supported the idea that the SNP309 has different ethnic effects. Regarding association of MDM2 SNP309 polymorphism with gender, clinical parameters, or hematological findings in the studied AML cases, a MDM2 and p53 polymorphism in AML 453 highly significant correlation was found only between the MDM2 SNP309 TG, GG genotypes, and the Hb level (p=0.001). Other than the Hb level, we did not observe any correlation between MDM2 SNP309 polymorphism and the other studied parameters. Xiong et al. did not identify any correlation between MDM2 SNP309 and gender, clinical parameters, and hematological findings [15]. In our study, we observed that the p53 codon 72 polymorphism did not affect the age onset of AML. We also did not associate the p53 codon 72 polymorphism with gender, clinical parameters or hematological findings of the studied cases, besides a correlation between p53 genotypes and the myeloid marker CD117 (p=0.004). Our results are consistent with the results of the Xiong et al. [15] study in the northern Chinese population and those of Nakano et al. [34]. In our study, the combination of the MDM2 SNP309 and p53 codon 72 polymorphisms among the studied groups was examined, and a borderline significant correlation drawn between the MDM2 TG and p53 genotypes (p=0.049). This suggested a possible interactive effect between the MDM2 309TG and the p53 genotypes in increasing the risk of AML. Similarly, Ellis et al. [24] reported that individuals carrying both an MDM2 G allele and a P53 Pro allele were at increased risk of t-aml. A meta-analysis of six studies conducted on 27,813 cases with various tumor types and 30,295 controls indicated a possible compounding effect between the MDM2 309GG and p53 Pro/Pro genotype that lead to a significantly increased risk of cancer [35]. However, the Xiong et al. study [15] showed no multiplicative effect of interaction between MDM2 SNP309 and p53 codon 72 polymorphisms and risk of AML. Again, this difference may be due to ethnic and/or geographic variations of the frequency of these alleles in different populations [26,27].
6 454 In conclusion, our study suggested that the interactive effect between the MDM2 SNP309 and p53 codon 72 polymorphisms may increase the risk of acute myeloid leukemia. Neither the MDM2 SNP309 nor p53 codon 72 polymorphisms increased the risk of acute myeloid leukemia. Our results showed a significant correlation between the MDM2 SNP309 variant genotypes, age of onset of AML, and Hb level. A significant correlation between p53 genotypes and the myeloid marker CD117 was also found. Acknowledgements We thank our patients for their willing participation in our research. There is no conflict of interest. References Annals of Clinical & Laboratory Science, vol. 44, no. 4, Deschler B and Lubbert M: Acute myeloid leukemia: epidemiology and etiology. Cancer 2006; 107: Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278(5340): Martens JH and Stunnenberg HG. The molecular signature of oncofusion proteins in acute myeloid leukemia. FEBS Lett. 2010; 584(12): Swerdlow SH, Campo E,Harris NL, et al.: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2009). Lyon: IARC. 5. Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 2000; 408 (6810): Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997; 88(3): Bourdon JC, Laurenzi VD, Melino G, Lane D: p53: 25 years of research and more questions to answer. Cell Death Differ 2003; 10(4): Feki A, Irminger-Finger I: Mutational spectrum of p53 mutations in primary breast and ovarian tumors. Crit Rev Oncol Hematol 2004; 52(2): Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP: Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 1996; 274(5289): Bond GL, Hu W, Bond EE, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 2004; 119: Nayak MS, Yang J-M, Hait WN. Effect of a single nucleotide polymorphism in the Murine Double Minute 2 promoter (SNP309) on the sensitivity to topoisomerase II-targeting drugs. Cancer Res 2007; 67: Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias French American British (FAB) co-operative group. Br J Haematol 1976; 33(4): Lo Coco F, Foa R. Diagnostic and prognostic advances in the immunophenotypic and genetic characterization of acute leukaemia. Eur J Haematol 1995; 55(1): Hoehn D, Medeiros LJ, Chen SS, Tian T, Jorgensen JL, Ahmed Y, Lin P. CD117 expression is a sensitive but non-specific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/Myeloid acute leukemia. Am J Clin path 2012; 137: Xiong X, Wang M, Wang L, Liu J, Zhao X, Tian Z, Wang J. Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia. Leukemia Research 2009; 33 (2009) National Cancer Institute (NCI) registry: National Cancer Institute Statistics Department of Biostatistics and Cancer Epidemiology, NCI Cairo, Ibrahim AS, Hussein H and Ismail K: Descriptive Epidemiology. In: Triennial Report of Gharbiah populationbased cancer registry (GPCR) 2007, Ye Z and Song H: Glutathione S-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukemia: a systematic review and meta-analysis. Eur J Cancer 2005; 41: Zhang MY, Chen FY and Zhong H: Meta-analysis of human leukocyte antigen genetic polymorphisms and susceptibility to chronic myelogenous leukemia in Chinese population. Leuk Res 2011; 35: Yan J, Yin M, Dreyer ZE et al: A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr Blood Cancer 2012; 58: Zhuo W, Zhang L, Ling J, Zhu B and Chen Z: MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects. Leukemia and Lymphoma 2012; : Wu H and Leng RP: UBE4B, an ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation. Cell Cycle 2011; 10: Ebid GT, Sedhom IA, El-Gammal MM, Moneer MM: MDM2 T309G has a Synergistic Effect with P21 ser31arg Single Nucleotide Polymorphisms on the Risk of Acute Myeloid Leukemia. Asian Pacific J Cancer Prev 2012; 13 (9), Ellis NA, Huo D, Yildiz O, Worrillow LJ, Banerjee M, Le Beau MM et al: MDM2 SNP309 and Tp53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. Blood 2008; 112(3): Phang BH, Linn YC, Li H and Sabapathy K: MDM2 SNP309 G allele decreases risk but doesn t affect onset age or survival of Chinese leukemia patients. Eur J Cancer 2008; 44(5): Harris SL, Gil G, Robins H et al: Detection of functional single nucleotide polymorphisms that affect apoptosis. Proc Nat Acad Sci USA 2005; 102(45): Bond GL and Levine AJ: A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans. Oncogene 2007;26 (9): Wojcik I, Szybka M, Golanska E et al: Abnormalities of the p53, MDM2, Bcl2 and BAX genes in acute leukemias. Neoplasia 2005; 52(4): Chauhan PS, Ihsan R, Yadav DS, Mishra AK, Bhushan B, Soni A, Kaushal M, Devi TR, Saluja S, Gupta DK, Mittal V, Saxena S and Kapur S: Association of glutathione S-transferase, EPHX, and p53 codon 72 gene polymorphisms with adult acute myeloid leukemia. DNA Cell Biol. 2011; 30(1): Weng Y, Lu L, Yuan G, Guo J, Zhang Z et al: P53 codon 72 polymorphism and Hematological Cancer Risk: An Update Meta-Analysis. PLoS ONE ; (9): e Dunna NR, Vure S, Sailaja K, Surekha D, Raghunadharao D, Rajappa S and Vishnupriya S: Tp53 codon 72 polymorphism and risk of acute leukemia. Asian Pac J Cancer Prev. 2012; 13(1): Swinney RM, Hsu SC, Hirschman BA et al: MDM2 promoter variation and age of diagnosis of acute lymphoblastic leukemia. Leukemia 2005; 19(11): Phillips CL, Gerbring R, Alonzo T et al: MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children s Oncology Group, Pediatr Blood Cancer 2010; 55(2): Nakano Y, Naoe T, Kiyoi H et al: Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia. Leuk. Res. 2000; 24(4): Wan Y, Wu W, Yin Z, Guan P and Zhou B: MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis. BMC Cancer 2011; 11: 208.
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma M.J. Wang, Y. Zhu, X.J. Guo and Z.Z. Tian Department of Orthopaedics, Xinxiang Central Hospital, Xinxiang,
More informationAssociation of CYP3A5*3 and CYP1A1*2C Polymorphism with Development of Acute Myeloid Leukemia in Egyptian Patients
DOI:10.22034/APJCP.2017.18.3.747 CYP3A5*3 and CYP1A1*2C Polymorphism in Egyptian Acute Myeloid Leukemia RESEARCH ARTICLE Association of CYP3A5*3 and CYP1A1*2C Polymorphism with Development of Acute Myeloid
More informationGenotyping of P53 Gene Exon 4 Codon 72 in Sudanese Patients with Myelogenous Leukaemias
EUROPEAN ACADEMIC RESEARCH Vol. II, Issue 6/ September 2014 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.1 (UIF) DRJI Value: 5.9 (B+) Genotyping of P53 Gene Exon 4 Codon 72 in ASIM MOKRAM MOHAMED
More informationMixed Phenotype Acute Leukemias
Mixed Phenotype Acute Leukemias CHEN GAO; AMY M. SANDS; JIANLAN SUN NORTH AMERICAN JOURNAL OF MEDICINE AND SCIENCE APR 2012 VOL 5 NO.2 INTRODUCTION Most cases of acute leukemia can be classified based
More informationInvestigation on ERCC5 genetic polymorphisms and the development of gastric cancer in a Chinese population
Investigation on ERCC5 genetic polymorphisms and the development of gastric cancer in a Chinese population L.Q. Yang 1, Y. Zhang 2 and H.F. Sun 3 1 Department of Gastroenterology, The Second Affiliated
More informationONE STEP MULTIPLEX RT-PCR FOR BCRlABL GENE IN MALAY PATIENTS DIAGNOSED AS LEUKAEMIA
ONE STEP MULTIPLEX RT-PCR FOR BCRlABL GENE IN MALAY PATIENTS DIAGNOSED AS LEUKAEMIA 1Rosline H, 1Majdan R, 1Wan Zaidah A, 1Rapiaah M, 1Selamah G, 2A A Baba, 3D M Donald 1Department of Haematology, 2Department
More informationCME/SAM. Mixed Phenotype Acute Leukemia
AJCP / Original Article Mixed Phenotype Acute Leukemia A Study of 61 Cases Using World Health Organization and European Group for the Immunological Classification of Leukaemias Criteria Olga K. Weinberg,
More informationTest Name Results Units Bio. Ref. Interval. Positive
LL - LL-ROHINI (NATIONAL REFERENCE 135091534 Age 36 Years Gender Female 1/9/2017 120000AM 1/9/2017 105316AM 2/9/2017 104147AM Ref By Final LEUKEMIA GENETIC ROFILE ANY SIX MARKERS, CR QUALITATIVE AML ETO
More informationTherapy-related MDS/AML with KMT2A (MLL) Rearrangement Following Therapy for APL Case 0328
Therapy-related MDS/AML with KMT2A (MLL) Rearrangement Following Therapy for APL Case 0328 Kenneth N. Holder, Leslie J. Greebon, Gopalrao Velagaleti, Hongxin Fan, Russell A. Higgins Initial Case: Clinical
More informationSUPPLEMENTARY INFORMATION
Supplementary Information S1 Frequency of DNMT3A mutations in hematologic disorders and their associated clinical phenotypes. Disease Patient population Frequency (%) Associated Clinical Characteristics
More informationAssociation between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population
Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population R. Zhao and M.F. Ying Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University,
More informationHLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma
HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma Arezou Sayad 1, Mohammad Taghi Akbari 2**, Mahshid Mehdizadeh 3,4, Mohammad Taheri 1, Abbas Hajifathali 3* 1 Department of Medical
More informationTest Name Results Units Bio. Ref. Interval. Positive
LL - LL-ROHINI (NATIONAL REFERENCE 135091533 Age 28 Years Gender Male 1/9/2017 120000AM 1/9/2017 105415AM 4/9/2017 23858M Ref By Final LEUKEMIA DIAGNOSTIC COMREHENSIVE ROFILE, ANY 6 MARKERS t (1;19) (q23
More informationAssociation between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer
Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer M.G. He, K. Zheng, D. Tan and Z.X. Wang Department of Hepatobiliary Surgery, Nuclear Industry 215 Hospital
More informationPolymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women
www.bioinformation.net Volume 13(5) Hypothesis Polymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women Maniraja Jesintha
More informationOriginal Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk in a Chinese Han population
Int J Clin Exp Med 2014;7(12):5832-5836 www.ijcem.com /ISSN:1940-5901/IJCEM0002117 Original Article The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk
More informationDiagnostic challenge: Acute leukemia with biphenotypic blasts and BCR-ABL1 translocation
Case Study Diagnostic challenge: Acute leukemia with biphenotypic blasts and BCR-ABL1 translocation Ling Wang 1 and Xiangdong Xu 1,2,* 1 Department of Pathology, University of California, San Diego; 2
More informationAberrant Expression of CD7 in Myeloblasts Is Highly Associated With De Novo Acute Myeloid Leukemias With FLT3/ITD Mutation
Hematopathology / CD7 Expression and FLT3/ITD Mutation in AML Aberrant Expression of CD7 in Myeloblasts Is Highly Associated With De Novo Acute Myeloid Leukemias With FLT3/ITD Mutation Veronica Rausei-Mills,
More informationExploring the Importance of Single Nucleotide Polymorphisms of HSPA9 in DNA of Sarcoma Patients
University of New Hampshire University of New Hampshire Scholars' Repository Honors Theses and Capstones Student Scholarship Summer 2013 Exploring the Importance of Single Nucleotide Polymorphisms of HSPA9
More informationAssociation between IL-17A and IL-17F gene polymorphisms and risk of gastric cancer in a Chinese population
Association between IL-17A and IL-17F gene polymorphisms and risk of gastric cancer in a Chinese population W.M. Zhao 1, P. Shayimu 1, L. Liu 1, F. Fang 1 and X.L. Huang 2 1 Department of Gastrointestinal
More informationMolecular Markers in Acute Leukemia. Dr Muhd Zanapiah Zakaria Hospital Ampang
Molecular Markers in Acute Leukemia Dr Muhd Zanapiah Zakaria Hospital Ampang Molecular Markers Useful at diagnosis Classify groups and prognosis Development of more specific therapies Application of risk-adjusted
More informationHuman leukocyte antigen-b27 alleles in Xinjiang Uygur patients with ankylosing spondylitis
Human leukocyte antigen-b27 alleles in Xinjiang Uygur patients with ankylosing spondylitis H.-Y. Zou, W.-Z. Yu, Z. Wang, J. He and M. Jiao Institute of Clinical Medicine, Urumqi General Hospital, Lanzhou
More informationMyoglobin A79G polymorphism association with exercise-induced skeletal muscle damage
Myoglobin A79G polymorphism association with exercise-induced skeletal muscle damage T. Cui and M.S. Jiang College of Physical Education, Shandong University of Finance and Economics, Ji nan, Shandong,
More informationRole of FISH in Hematological Cancers
Role of FISH in Hematological Cancers Thomas S.K. Wan PhD,FRCPath,FFSc(RCPA) Honorary Professor, Department of Pathology & Clinical Biochemistry, Queen Mary Hospital, University of Hong Kong. e-mail: wantsk@hku.hk
More informationAssociation between MTHFR 677C/T and 1298A/C gene polymorphisms and breast cancer risk
Association between MTHFR 677C/T and 1298A/C gene polymorphisms and breast cancer risk X.F. Zhang 1, T. Liu 2, Y. Li 1 and S. Li 2 1 Department of Breast, Liao Ning Cancer Hospital and Institute, Shenyang,
More informationInvestigating the role of polymorphisms in mir-146a, -149, and -196a2 in the development of gastric cancer
Investigating the role of polymorphisms in mir-146a, -149, and -196a2 in the development of gastric cancer Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong
More informationPeking University People's Hospital, Peking University Institute of Hematology
Qian Jiang, M.D. Peking University People's Hospital, Peking University Institute of Hematology No. 11 Xizhimen South Street, Beijing, 100044, China. Phone number: 86-10-66583802 Mobile: 86-13611115100
More informationABERRANT EXPRESSION OF CD19 AND CD43
ABERRANT EXPRESSION OF CD19 AND CD43 IN A PATIENT WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA AND A HISTORY OF MANTLE CELL LYMPHOMA Yen-Chuan Hsieh, 1 Chien-Liang Lin, 2 Chao-Jung Tsao, 2 Pin-Pen Hsieh,
More informationCase 1. Sa A.Wang, MD UT MD Anderson Cancer Center Houston, TX
Case 1 Sa A.Wang, MD UT MD Anderson Cancer Center Houston, TX Disclosure of Relevant Financial Relationships The USCAP requires that anyone in a position to influence or control the content of all CME
More informationH.F. Liu, J.S. Liu, J.H. Deng and R.R. Wu. Corresponding author: J.S. Liu
Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics H.F. Liu, J.S. Liu, J.H. Deng and R.R. Wu Department
More informationDepartment of Respiratory Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China
Association of glutathione S-transferase (GST) genetic polymorphisms with treatment outcome of cisplatin-based chemotherapy for advanced non-small cell lung cancer in a Chinese population H.L. Xiao 1,
More informationExpression of Micro-RNA 128 and Let-7b in Pediatric Acute Lymphoblastic Leukemia Cases
DOI:10.22034/APJCP.2018.19.8.2263 RESEARCH ARTICLE Editorial Process: Submission:03/05/2018 Acceptance:07/17/2018 Expression of Micro-RNA 128 and Let-7b in Pediatric Acute Lymphoblastic Leukemia Cases
More informationSupplemental Material. The new provisional WHO entity RUNX1 mutated AML shows specific genetics without prognostic influence of dysplasia
Supplemental Material The new provisional WHO entity RUNX1 mutated AML shows specific genetics without prognostic influence of dysplasia Torsten Haferlach, 1 Anna Stengel, 1 Sandra Eckstein, 1 Karolína
More informationAssociation between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk
Association between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk B.B. Sun, J.Z. Wu, Y.G. Li and L.J. Ma Department of Respiratory Medicine, People s Hospital Affiliated to
More informationGenetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients
Genetic variability of DNA repair mechanisms in chemotherapy treatment outcome of gastric cancer patients G. Zhong 1, H.K. Li 2, T. Shan 1 and N. Zhang 1 1 Department of Gastrointestinal Surgery, Tianjin
More informationAward Number: W81XWH TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer
AD Award Number: W81XWH-04-1-0579 TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer PRINCIPAL INVESTIGATOR: Yuichiro Tanaka, Ph.D. Rajvir Dahiya, Ph.D. CONTRACTING ORGANIZATION:
More informationLack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population
Lack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population J.J. Lu, H.Q. Zhang, P. Mai, X. Ma, X. Chen, Y.X. Yang and L.P. Zhang Gansu Provincial Hospital, Donggang
More informationSWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017
LEUKEMIA FORMS The guidelines and figures below are specific to Leukemia studies. The information in this manual does NOT represent a complete set of required forms for any leukemia study. Please refer
More informationHematopathology Service Memorial Sloan Kettering Cancer Center, New York
SH2017-0334 t(14;18) Negative Follicular Lymphoma with 1p36 abnormality associated with In Situ Follicular Neoplasia with t(14;18) translocation Pallavi Khattar MD, Jennifer Maerki MD, Alexander Chan MD,
More informationAllelic and Haplotype Frequencies of the p53 Polymorphisms in Brain Tumor Patients
Physiol. Res. 51: 59-64, 2002 Allelic and Haplotype Frequencies of the p53 Polymorphisms in Brain Tumor Patients E. BIROŠ, I. KALINA, A. KOHÚT 1, E. BOGYIOVÁ 2, J. ŠALAGOVIČ, I. ŠULLA 3 Department of Medical
More informationMolecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC
Molecular Markers Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC Overview Testing methods Rationale for molecular testing
More informationCYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women
CYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women L. Yang, X.Y. Wang, Y.T. Li, H.L. Wang, T. Wu, B. Wang, Q. Zhao, D. Jinsihan and L.P. Zhu The Department of Mammary
More informationPredictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer
Predictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer X. Wang 1,2 and Z.H. Huang 1 1 Department of General Surgery, Zhujiang Hospital, Southern Medical
More informationBCR-ABL1 positive Myeloid Sarcoma Nicola Austin
BCR-ABL1 positive Myeloid Sarcoma Nicola Austin Cytocell UK & Ireland User Group Meeting Jesus College, Cambridge 4 th - 5 th April 2017 Myeloid Sarcoma WHO Classification Tumours of Haematopoietic and
More informationConcomitant WT1 mutations predicted poor prognosis in CEBPA double-mutated acute myeloid leukemia
Concomitant WT1 mutations predicted poor prognosis in CEBPA double-mutated acute myeloid leukemia Feng-Ming Tien, Hsin-An Hou, Jih-Luh Tang, Yuan-Yeh Kuo, Chien-Yuan Chen, Cheng-Hong Tsai, Ming Yao, Chi-Cheng
More informationAssociation between matrix metalloproteinase-9 rs polymorphism and development of coronary artery disease in a Chinese population
Association between matrix metalloproteinase-9 rs3918242 polymorphism and development of coronary artery disease in a Chinese population L.M. Qin 1, G.M. Qin 2, X.H. Shi 1, A.L. Wang 1 and H. Zuo 1 1 The
More informationInvestigation of the role of XRCC1 genetic polymorphisms in the development of gliomas in a Chinese population
Investigation of the role of XRCC1 genetic polymorphisms in the development of gliomas in a Chinese population S.C. Fan 1, J.G. Zhou 2 and J.Z. Yin 1 1 Department of Neurosurgery, The People s Hospital
More informationEuropean Journal of Medical Research. Open Access RESEARCH. Weiming Hao 1,2, Xia Xu 3, Haifeng Shi 1, Chiyu Zhang 2 and Xiaoxiang Chen 4*
https://doi.org/10.1186/s40001-018-0345-6 European Journal of Medical Research RESEARCH Open Access No association of TP53 codon 72 and intron 3 16 bp duplication polymorphisms with breast cancer risk
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationTITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer
AD Award Number: W81XWH-04-1-0579 TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer PRINCIPAL INVESTIGATOR: Yuichiro Tanaka, Ph.D. CONTRACTING ORGANIZATION: Northern California
More informationDifferentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell
Differentiation-induced Changes of Mediterranean Fever Gene (MEFV) Expression in HL-60 Cell Wenxin Li Department of Biological Sciences Fordham University Abstract MEFV is a human gene that codes for an
More informationNature Genetics: doi: /ng Supplementary Figure 1. Study design.
Supplementary Figure 1 Study design. Leukopenia was classified as early when it occurred within the first 8 weeks of thiopurine therapy and as late when it occurred more than 8 weeks after the start of
More informationObjectives. Morphology and IHC. Flow and Cyto FISH. Testing for Heme Malignancies 3/20/2013
Molecular Markers in Hematologic Malignancy: Ways to locate the needle in the haystack. Objectives Review the types of testing for hematologic malignancies Understand rationale for molecular testing Marcie
More informationMyelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data
Instructions for Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data (Form 2114) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Myelodysplasia/Myeloproliferative
More informationAssociation of GSTTI and GSTM1 variants with acute myeloid leukemia risk
Association of GSTTI and GSTM variants with acute myeloid leukemia risk Y.M. Zi, S. Wu, D. Ma 2, C. Yang, M. Yang, Y. Huang and S.J. Yang 3 Department of Hematology, The First Affiliated Hospital, Xinxiang
More informationPacharapan Surapolchai, MD Associate Professor Department of Pediatrics, Faculty of Medicine, Thammasat University, Thailand October 2018
Pacharapan Surapolchai, MD Associate Professor Department of Pediatrics, Faculty of Medicine, Thammasat University, Thailand October 2018 Outline Case study Introduction of Current management of infantile
More informationCLASSIFICATION OF NINETY-EIGHT ADULT CASES OF ACUTE LEUKEMIAS ACCORDING TO MORPHOLOGY, IMMUNOLOGY AND CYTOGENETICS
( ;hinese Journal qf()ancer Research 8(3): 209 ~ 13, 1996. CLASSIFICATION OF NINETY-EIGHT ADULT CASES OF ACUTE LEUKEMIAS ACCORDING TO MORPHOLOGY, IMMUNOLOGY AND CYTOGENETICS Li Jianyong ~2tt[. N Xue Yongquan
More informationPolymorphisms in lncrna HOTAIR and Susceptibility to Acute Myeloid Leukemia in Iranian Patients
Journal of Biology and Today's World Received: 04 November 2016 Accepted: 07 March 2017 Journal home page: http://journals.lexispublisher.com/jbtw Research doi:10.15412/j.jbtw.01060203 Polymorphisms in
More informationSmoking, human papillomavirus infection, and p53 mutation as risk factors in oropharyngeal cancer: a case-control study
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Smoking, human papillomavirus infection, and p53 as risk factors in oropharyngeal cancer: a case-control study PKS Chan *, JSY Chor, AC Vlantis, TL
More informationAberrant DNA methylation of MGMT and hmlh1 genes in prediction of gastric cancer
Aberrant DNA methylation of MGMT and hmlh1 genes in prediction of gastric cancer J. Jin 1,2, L. Xie 2, C.H. Xie 1 and Y.F. Zhou 1 1 Department of Radiation & Medical Oncology, Zhongnan Hospital of Wuhan
More informationInfluence of interleukin-17 gene polymorphisms on the development of pulmonary tuberculosis
Influence of interleukin-17 gene polymorphisms on the development of pulmonary tuberculosis G.-C. Shi and L.-G. Zhang Department of Tuberculosis, The First Affiliated Hospital of Xinxiang Medical University,
More informationDownregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases
Brief Communication Downregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases Qinghai Zeng 1 *, Cuihong Jin 2 *, Wenhang Chen 2, Fang Xia 3, Qi Wang 3, Fan Fan 4,
More informationInfluence of the c.1517g>c genetic variant in the XRCC1 gene on pancreatic cancer susceptibility in a Chinese population
Influence of the c.1517g>c genetic variant in the XRCC1 gene on pancreatic cancer susceptibility in a Chinese population Z.M. Zhao*, C.G. Li*, M.G. Hu, Y.X. Gao and R. Liu Department of Surgical Oncology,
More informationClinical Significance of Serum p53 and Epidermal Growth Factor Receptor in Patients with Acute Leukemia
RESEARCH ARTICLE Clinical Significance of Serum p53 and Epidermal Growth Factor Receptor in Patients with Acute Leukemia Abstract Background: Pretreatment serum p53 and epidermal growth factor receptor
More informationInvestigation of GSTP1 (Ile105Val) Gene Polymorphism in Chronic Myeloid Leukaemia Patients
Kamla-Raj 2012 Int J Hum Genet, 12(3): 145-149 (2012) Investigation of GSTP1 (Ile105Val) Gene Polymorphism in Chronic Myeloid Leukaemia Patients Mutlu Karkucak 1,2,*, Tahsin Yakut 2, Tuna Gulten 2 and
More informationMyelodysplastic Syndrome Case 158
Myelodysplastic Syndrome Case 158 Dong Chen MD PhD Division of Hematopathology Mayo Clinic Clinical History 86 year old man Persistent borderline anemia and thrombocytopenia. His past medical history was
More informationBeyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure
Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for
More informationIL10 rs polymorphism is associated with liver cirrhosis and chronic hepatitis B
IL10 rs1800896 polymorphism is associated with liver cirrhosis and chronic hepatitis B L.N. Cao 1, S.L. Cheng 2 and W. Liu 3 1 Kidney Disease Department of Internal Medicine, Xianyang Central Hospital,
More informationNucleic Acid Testing - Oncology. Molecular Diagnosis. Gain/Loss of Nucleic Acid. Objectives. MYCN and Neuroblastoma. Molecular Diagnosis
Nucleic Acid Testing - Oncology Molecular Diagnosis Nucleic acid based testing in Oncology Gross alterations in DNA content of tumors (ploidy) Gain/Loss of nucleic acids Markers of Clonality Oncogene/Tumor
More informationMicroRNA-29a Reveals Oncogenic Role on Myeloid Malignancies by Regulating DNMT3A
MicroRNA-29a Reveals Oncogenic Role on Myeloid Malignancies by Regulating DNMT3A Heba Alkhatabi, PhD Assistant Professor Department of Medical Laboratory Collage of Applied Medical science King Abdul Aziz
More informationMolecular Diagnosis. Nucleic acid based testing in Oncology
Molecular Diagnosis Nucleic acid based testing in Oncology Objectives Describe uses of NAT in Oncology Diagnosis, Prediction, monitoring. Genetics Screening, presymptomatic testing, diagnostic testing,
More informationOriginal Article. Clinical features and outcome of acute myeloid leukemia, a single institution experience in Saudi Arabia INTRODUCTION
Original Article Clinical features and outcome of acute myeloid leukemia, a single institution experience in Saudi Arabia Ahmed Al Faleh 4, Abdullah Al-Quozi 2,3,4, Ahmed Alaskar 1,3,4, Mohsen Al Zahrani
More informationTemplate for Reporting Results of Biomarker Testing for Myeloproliferative Neoplasms
Template for Reporting Results of Biomarker Testing for Myeloproliferative Neoplasms Version: MPNBiomarkers 1.0.0.2 Protocol Posting Date: June 2017 This biomarker template is NOT required for accreditation
More informationAssociation of Arg72Pro of P53 Polymorphism with Colorectal Cancer Susceptibility Risk in Malaysian Population
RESEARCH COMMUNICATION Association of Arg72Pro of P53 Polymorphism with Colorectal Cancer Susceptibility Risk in Malaysian Population Abdul Aziz Ahmad Aizat 1, Siti Nurfatimah Mohd Shahpudin 1, Mohd Aminudin
More informationInvestigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma
Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma Q. Zhang 1, L.Y. Lv 1, B.J. Li 1, J. Zhang 1 and F. Wei 2 1 Department of Orthopaedics,
More informationSurvival Inequalities among Children, Adolescents and Young Adults with Acute Leukemia in California Renata Abrahão, MD MSc PhD
Survival Inequalities among Children, Adolescents and Young Adults with Acute Leukemia in California Renata Abrahão, MD MSc PhD California Cancer Registrars Association Sacramento November 3 rd, 2016 Objectives
More informationGroup of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and
Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and / or peripheral blood Classified based on cell type
More informationOncofocus. Patient Test Report
Oncofocus Patient Test Report Lead Clinical Scientist: Keeda Snelson BMS: Tiffany Haddow Date: 22 Dec 2016 1 of 4 Comment: The DNA and RNA extracted from this sample were of optimal quality. The Oncofocus
More informationTherapy-related acute myeloid leukemia with germline TP53 mutation (Li-Fraumeni syndrome) SH Chelsey Deel MD Teresa Scordino MD
Therapy-related acute myeloid leukemia with germline TP53 mutation (Li-Fraumeni syndrome) SH2017-167 Chelsey Deel MD Teresa Scordino MD Clinical History HPI: 44 year old Caucasian female referred for evaluation
More informationMast Cell Disease Case 054 Session 7
Mast Cell Disease Case 054 Session 7 Rodney R. Miles, M.D., Ph.D. Lauren B. Smith, M.D. Cem Akin, M.D. Diane Roulston,, Ph.D. Charles W. Ross, M.D. Departments of Pathology and Internal Medicine University
More informationAssociation between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis
Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Y. Liu, H.L. Liu, W. Han, S.J. Yu and J. Zhang Department of Cardiology, The General Hospital of the
More informationNUP214-ABL1 Fusion: A Novel Discovery in Acute Myelomonocytic Leukemia
Case 0094 NUP214-ABL1 Fusion: A Novel Discovery in Acute Myelomonocytic Leukemia Jessica Snider, MD Medical University of South Carolina Case Report - 64 year old Caucasian Male Past Medical History Osteoarthritis
More informationTest Name Results Units Bio. Ref. Interval. Positive
Lab No 135091548 Age 35 Years Gender Female 1/9/2017 120000AM 1/9/2017 103420AM 4/9/2017 23753M Ref By Dr UNKNWON Final Test Results Units Bio Ref Interval LEUKEMIA DIAGNOSTIC COMREHENSIVE ROFILE 3 t (1;19)
More informationAssociation between p53 codon 72 polymorphisms and clinical outcome of nasopharyngeal carcinoma
Association between p53 codon 72 polymorphisms and clinical outcome of nasopharyngeal carcinoma M.L. Li 1,2, Y. Dong 3, Y.Z. Hao 2, N. Xu 2, F.L. Ning 2, S.S. Chen 2 and J.M. Yu 4 1 Division of Medicine,
More informationRole of Paired Box9 (PAX9) (rs ) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis
EC Dental Science Special Issue - 2017 Role of Paired Box9 (PAX9) (rs2073245) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis Research Article Dr. Sonam Sethi 1, Dr. Anmol
More informationIntroduction to Genetics
Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist
More informationADx Bone Marrow Report. Patient Information Referring Physician Specimen Information
ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS
More informationGenetic Polymorphism of DNA Repair Gene (OGG1) In Iraqi Acute Myeloid Leukemia Patients
Genetic Polymorphism of DNA Repair Gene (OGG1) In Iraqi Acute Myeloid Leukemia Patients Rasha A.Tuama College of Science For Women, Baghdad University. Nagham E. Al-Essa College of Science For Women, Baghdad
More informationMassoud Houshmand National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
QUID 2017, pp. 669-673, Special Issue N 1- ISSN: 1692-343X, Medellín-Colombia NON-GENE REGION AND INFLUENCES TUMOR CHARACTERISTICS BY LOW-RISK ALLELES IN BREAST CANCER (Recibido el 21-06-2017. Aprobado
More informationReporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota
Reporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota Reporting cytogenetics What is it? Terminology Clinical value What details are important Diagnostic Tools for Leukemia
More informationReview Article The TP53 codon 72 Pro/Pro genotype may be associated with an increased lung cancer risk in North China: an updated meta-analysis
Int J Clin Exp Med 2015;8(3):3120-3126 www.ijcem.com /ISSN:1940-5901/IJCEM0004181 Review Article The TP53 codon 72 / genotype may be associated with an increased lung cancer risk in North China: an updated
More informationThe risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis
(2012) 14, 726 731 ß 2012 AJA, SIMM & SJTU. All rights reserved 1008-682X/12 $32.00 www.nature.com/aja ORIGINAL ARTICLE The risks, degree of malignancy and clinical progression of prostate cancer associated
More informationADVANCES IN CHILDHOOD ACUTE LEUKEMIAS : GENERAL OVERVIEW
ADVANCES IN CHILDHOOD ACUTE LEUKEMIAS : GENERAL OVERVIEW Danièle SOMMELET European Scientific Seminar Luxemburg, 3.11.2009 1 Definition of acute leukemias Malignant process coming from lymphoid (85 %)
More informationmir-146a and mir-196a2 polymorphisms in ovarian cancer risk
mir-146a and mir-196a2 polymorphisms in ovarian cancer risk X.C. Sun, A.C. Zhang, L.L. Tong, K. Wang, X. Wang, Z.Q. Sun and H.Y. Zhang Department of Obstetrics and Gynecology, China-Japan Union Hospital
More informationRESEARCH ARTICLE. Prevalence of CTR1 and ERCC1 Polymorphisms and Response of Biliary Tract Cancer to Gemcitabine-Platinum Chemotherapy
RESEARCH ARTICLE Prevalence of CTR1 and ERCC1 Polymorphisms and Response of Biliary Tract Cancer to Gemcitabine-Platinum Chemotherapy Skolchart Pongmaneratanakul 1, Suebpong Tanasanvimon 2, Thitima Pengsuparp
More informationoncogenes-and- tumour-suppressor-genes)
Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging
More informationNew evidence of TERT rs polymorphism and cancer risk: an updated meta-analysis
JBUON 2016; 21(2): 491-497 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE New evidence of TERT rs2736098 polymorphism and risk: an updated meta-analysis
More informationSubmitted to Leukemia as a Letter to the Editor, May Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69.
Submitted to Leukemia as a Letter to the Editor, May 2007 To the Editor, Leukemia :- Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69. Gender plays an important role in the incidence,
More informationHaematology Probes for Multiple Myeloma
Haematology Probes for Multiple Myeloma MULTIPLE MYELOMA Multiple myeloma (MM) is a plasma cell neoplasm, characterised by the accumulation of clonal plasma cells in the bone marrow and by very complex
More informationAssociation of p53 Codon 72 Genotypes and Clinical Outcome in Human Papillomavirus- Infected Lung Cancer Patients
GENERAL THORACIC Association of p53 Codon 72 Genotypes and Clinical Outcome in Human Papillomavirus- Infected Lung Cancer Patients Shih-Pin Chen, MD,* Nan-Yung Hsu, MD, PhD,* Jeng-Yuan Wu, MD, PhD, Chih-Yi
More information